FBXO9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.141900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.583800E-01
Normal-vs-Stage2
3.896300E-03
Normal-vs-Stage3
7.662000E-03
Normal-vs-Stage4
1.417010E-01
Stage1-vs-Stage2
1.282400E-02
Stage1-vs-Stage3
4.695700E-02
Stage1-vs-Stage4
4.933800E-01
Stage2-vs-Stage3
6.388000E-02
Stage2-vs-Stage4
3.966200E-01
Stage3-vs-Stage4
5.290100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.708000E-02
Normal-vs-AfricanAmerican
2.197800E-02
Normal-vs-Asian
2.588300E-02
Caucasian-vs-AfricanAmerican
9.561200E-01
Caucasian-vs-Asian
6.264400E-01
AfricanAmerican-vs-Asian
6.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.097900E-02
Normal-vs-Female
8.750400E-02
Male-vs-Female
7.136200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.613600E-01
Normal-vs-Age(41-60Yrs)
6.964400E-02
Normal-vs-Age(61-80Yrs)
7.341600E-02
Normal-vs-Age(81-100Yrs)
1.320080E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.047400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.271800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.186200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.296400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.323400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.599600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.584700E-04
Normal-vs-Daily Drinker
1.121320E-03
Normal-vs-Weekly Drinker
3.015900E-02
Normal-vs-Occasional Drinker
6.092800E-01
Normal-vs-Social Drinker
8.955500E-02
Non Drinker-vs-Daily Drinker
4.624600E-01
Non Drinker-vs-Weekly Drinker
1.261400E-01
Non Drinker-vs-Occasional Drinker
1.309440E-01
Non Drinker-vs-Social Drinker
6.091600E-02
Daily Drinker-vs-Weekly Drinker
5.717700E-02
Daily Drinker-vs-Occasional Drinker
8.292400E-02
Daily Drinker-vs-Social Drinker
3.144100E-02
Weekly Drinker-vs-Occasional Drinker
3.893200E-01
Weekly Drinker-vs-Social Drinker
7.212800E-01
Occasional Drinker-vs-Social Drinker
5.198400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.147600E-01
Normal-vs-Grade 2
1.798360E-01
Normal-vs-Grade 3
2.723800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.119800E-02
Grade 1-vs-Grade 3
4.042400E-02
Grade 1-vs-Grade 4
3.147600E-01
Grade 2-vs-Grade 3
4.186000E-01
Grade 2-vs-Grade 4
1.798360E-01
Grade 3-vs-Grade 4
2.723800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.282500E-02
Normal-vs-NonDiabetic
6.985500E-02
Diabetic-vs-NonDiabetic
3.355200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.577400E-03
Normal-vs-NoPancreatitis
7.561700E-02
Pancreatitis-vs-NoPancreatitis
3.704800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.675000E-01
Normal-vs-N1
2.639300E-03
N0-vs-N1
1.157960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.721630E-01
Normal-vs-TP53-NonMutant
5.912400E-01
TP53-Mutant-vs-TP53-NonMutant
2.74960000001823E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
